287 related articles for article (PubMed ID: 16456141)
1. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease.
Wilkinson TM; Donaldson GC; Johnston SL; Openshaw PJ; Wedzicha JA
Am J Respir Crit Care Med; 2006 Apr; 173(8):871-6. PubMed ID: 16456141
[TBL] [Abstract][Full Text] [Related]
2. Detection of adenovirus and respiratory syncytial virus in patients with chronic obstructive pulmonary disease: Exacerbation versus stable condition.
Kokturk N; Bozdayi G; Yilmaz S; Doğan B; Gulbahar O; Rota S; Tatlicioglu T
Mol Med Rep; 2015 Aug; 12(2):3039-46. PubMed ID: 25936369
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus persistence in chronic obstructive pulmonary disease.
Sikkel MB; Quint JK; Mallia P; Wedzicha JA; Johnston SL
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S63-70. PubMed ID: 18820581
[TBL] [Abstract][Full Text] [Related]
4. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease.
Falsey AR; Formica MA; Hennessey PA; Criddle MM; Sullender WM; Walsh EE
Am J Respir Crit Care Med; 2006 Mar; 173(6):639-43. PubMed ID: 16387798
[TBL] [Abstract][Full Text] [Related]
5. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease.
Seemungal T; Harper-Owen R; Bhowmik A; Moric I; Sanderson G; Message S; Maccallum P; Meade TW; Jeffries DJ; Johnston SL; Wedzicha JA
Am J Respir Crit Care Med; 2001 Nov; 164(9):1618-23. PubMed ID: 11719299
[TBL] [Abstract][Full Text] [Related]
6. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease.
Wilkinson TM; Patel IS; Wilks M; Donaldson GC; Wedzicha JA
Am J Respir Crit Care Med; 2003 Apr; 167(8):1090-5. PubMed ID: 12684248
[TBL] [Abstract][Full Text] [Related]
7. [Detection of respiratory syncytial virus in children with respiratory tract infections by nucleic acid amplification fluorogenic quantitative assay].
Tan ZT; Shi L; Lu GX; Xu W; Jia YP; Xing Y; Wu XL; Hu S; Ren Y; Wu LX
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Oct; 11(10):825-8. PubMed ID: 19849942
[TBL] [Abstract][Full Text] [Related]
8. Exacerbations of chronic obstructive pulmonary disease.
Wedzicha JA; Donaldson GC
Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
[TBL] [Abstract][Full Text] [Related]
10. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.
Chávez-Bueno S; Mejías A; Gómez AM; Olsen KD; Ríos AM; Fonseca-Aten M; Ramilo O; Jafri HS
Virol J; 2005 May; 2():46. PubMed ID: 15916706
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of the detection rate and load of rhinovirus in nasal versus lower airway samples from patients with chronic obstructive pulmonary disease].
Liao H; Chen R; Guan W; Yang Z; Liu W; Zhou R; Zhong N
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):21-3. PubMed ID: 24694969
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory response in acute viral exacerbations of COPD.
Rohde G; Borg I; Wiethege A; Kauth M; Jerzinowski S; An Duong Dinh T; Bauer TT; Bufe A; Schultze-Werninghaus G
Infection; 2008 Oct; 36(5):427-33. PubMed ID: 18795228
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a quantitative real-time PCR for the detection of respiratory syncytial virus in pulmonary diseases.
Borg I; Rohde G; Löseke S; Bittscheidt J; Schultze-Werninghaus G; Stephan V; Bufe A
Eur Respir J; 2003 Jun; 21(6):944-51. PubMed ID: 12797486
[TBL] [Abstract][Full Text] [Related]
14. [Metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in induced sputum in patients with asthma and chronic obstructive pulmonary disease and their relationship to airway inflammation and airflow limitation].
Xin XF; Zhao M; Li ZL; Song Y; Shi Y
Zhonghua Jie He He Hu Xi Za Zhi; 2007 Mar; 30(3):192-6. PubMed ID: 17572998
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and airway inflammation profile of COPD persistent sputum producers.
Khurana S; Ravi A; Sutula J; Milone R; Williamson R; Plumb J; Vestbo J; Singh D
Respir Med; 2014 Dec; 108(12):1761-70. PubMed ID: 25459449
[TBL] [Abstract][Full Text] [Related]
16. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
17. Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation.
Dentener MA; Vernooy JH; Hendriks S; Wouters EF
Thorax; 2005 Feb; 60(2):114-9. PubMed ID: 15681498
[TBL] [Abstract][Full Text] [Related]
18. Recognizing the importance of respiratory syncytial virus in chronic obstructive pulmonary disease.
Ramaswamy M; Groskreutz DJ; Look DC
COPD; 2009 Feb; 6(1):64-75. PubMed ID: 19229710
[TBL] [Abstract][Full Text] [Related]
19. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations.
Papi A; Bellettato CM; Braccioni F; Romagnoli M; Casolari P; Caramori G; Fabbri LM; Johnston SL
Am J Respir Crit Care Med; 2006 May; 173(10):1114-21. PubMed ID: 16484677
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for respiratory syncytial virus illness among patients with chronic obstructive pulmonary disease.
Mehta J; Walsh EE; Mahadevia PJ; Falsey AR
COPD; 2013 Jun; 10(3):293-9. PubMed ID: 23536980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
